Business
MMJ PhytoTech Ltd (MMJJF) MediPharm Labs (TSXV:LABS) Enters Contract with Supreme Cannabis
Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ"...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"MMJ PhytoTech Ltd (MMJJF) MediPharm Labs (TSXV:LABS) Enters Contract with Supreme Cannabis\nPerth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) (\"MMJ\") is pleased to attach a copy of a news release by MediPharm Labs Inc (\"MediPharm Labs\") (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc (\"Supreme Cannabis\") (CVE:FIRE). MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. To view the news release, please visit:http://abnnewswire.net/lnk/873PJPU0 \nAbout MMJ PhytoTech Ltd:MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/ \nSource:MMJ PhytoTech Ltd\nContact:Investor and Media Enquiries:\nJason Conroy\nChief Executive Officer\nT: +61-2-8098-0819\nE: [email protected]\n \n ","length":1470,"tagName":"div"}]